Practical implications of the 2016 revision of the world health organization classification of lymphoid and myeloid neoplasms and acute leukemia Review uri icon

Overview

MeSH Major

  • Leukemia, Myeloid, Acute
  • Lymphoma
  • World Health Organization

abstract

  • A major revision of the WHO classification of lymphoid and myeloid neoplasms and acute leukemia was released in 2016. A key motivation for this update was to include new information available since the 2008 version with clinical relevance for the diagnosis, prognosis, and therapy of patients. With > 100 entities described, it is important for the clinician to understand features that may be important in daily practice, whereas researchers need to incorporate the new classification scheme into study development and analysis. In this review, we highlight the key aspects of the 2016 update with particular importance to routine patient care and clinical trial design.

publication date

  • August 10, 2017

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2017.72.6745

PubMed ID

  • 28654364

Additional Document Info

start page

  • 2708

end page

  • 2715

volume

  • 35

number

  • 23